{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:00:08Z","timestamp":1760061608131,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["05320_126888\/1"],"award-info":[{"award-number":["05320_126888\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jpba.2016.05.018","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T01:16:06Z","timestamp":1463015766000},"page":"247-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development and full validation of an UPLC-MS\/MS method for the quantification of the plant-derived alkaloid indirubin in rat plasma"],"prefix":"10.1016","volume":"128","author":[{"given":"Evelyn A.","family":"J\u00e4hne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chethan","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Butterweck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hamburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-0018","authenticated-orcid":false,"given":"Mouhssin","family":"Oufir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.05.018_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/9035","article-title":"Indirubin, the active constituent of a Chinese antileukemia medicine","volume":"1","author":"Hoessel","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jpba.2016.05.018_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1026095608691","article-title":"Isatis tinctoria\u2013From the rediscovery of an ancient medicinal plant towards a novel anti-inflammatory phytopharmaceutical","volume":"1","author":"Hamburger","year":"2002","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.jpba.2016.05.018_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cbic.200400108","article-title":"From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors","volume":"6","author":"Jautelat","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.jpba.2016.05.018_bib0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5414\/CPP42656","article-title":"Novel indirubin derivatives, promising anti-tumor agents inhibiting cyclin-dependent kinases","volume":"42","author":"Merz","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2016.05.018_bib0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3\u03b2 and CDK5\/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer\u2019s disease","volume":"276","author":"Leclerc","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2016.05.018_bib0030","doi-asserted-by":"crossref","first-page":"31475","DOI":"10.1074\/jbc.C100238200","article-title":"Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine","volume":"276","author":"Adachi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2016.05.018_bib0035","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1038\/sj.onc.1207535","article-title":"Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins","volume":"23","author":"Knockaert","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jpba.2016.05.018_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00879-7","article-title":"Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity","volume":"410","author":"Kunikata","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2016.05.018_bib0045","doi-asserted-by":"crossref","first-page":"23425","DOI":"10.1074\/jbc.M602627200","article-title":"Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-\u03baB signaling pathway","volume":"281","author":"Sethi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2016.05.018_bib0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jm031016d","article-title":"Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases","volume":"47","author":"Polychronopoulos","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2016.05.018_bib0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.phymed.2008.01.004","article-title":"Determination and pharmacokinetic study of indirubin in rat plasma by high-performance liquid chromatography","volume":"15","author":"Deng","year":"2008","journal-title":"Phytomedicine"},{"article-title":"Guidance for Industry Bioanalytical Method Validation","year":"2001","series-title":"US Food and Drug Administration (FDA)","key":"10.1016\/j.jpba.2016.05.018_bib0060"},{"key":"10.1016\/j.jpba.2016.05.018_bib0065","unstructured":"Guideline on bioanalytical method validation. European Medicines Agency (EMEA\/CHMP\/EWP\/192217\/2009). London, 2011,21."},{"key":"10.1016\/j.jpba.2016.05.018_bib0070","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/jm980123i","article-title":"Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases","volume":"41","author":"Sun","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2016.05.018_bib0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2007-967105","article-title":"Quantification of active principles and pigments in leaf extracts of isatis tinctoria by HPLC\/UV\/MS","volume":"73","author":"Mohn","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.jpba.2016.05.018_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jchromb.2012.06.009","article-title":"Development and full validation of an UPLC-MS\/MS method for the determination of an anti-allergic indolinone derivative in rat plasma, and application to a preliminary pharmacokinetic study","volume":"902","author":"Oufir","year":"2012","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2016.05.018_bib0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpba.2014.05.026","article-title":"Development and validation of a LC-MS\/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models","volume":"98","author":"J\u00e4hne","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2016.05.018_bib0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.jpba.2016.05.018_bib0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0006-2952(89)90228-1","article-title":"Comparison of microsomal drug-metabolizing enzymes in 14 rat inbred strains","volume":"38","author":"Koster","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2016.05.018_bib0100","first-page":"1","article-title":"Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances","volume":"47","author":"Kacew","year":"1996","journal-title":"J. Toxicol. Environ. Health A."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516302576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516302576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T23:48:01Z","timestamp":1712447281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516302576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":20,"alternative-id":["S0731708516302576"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.05.018","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and full validation of an UPLC-MS\/MS method for the quantification of the plant-derived alkaloid indirubin in rat plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}